IL-6 at the center of cytokine storm: Circulating inflammation mediators as biomarkers in hospitalized COVID-19 patients.

Hossein Mostafa ElbadawyAmin KhattabDina S El-AgamyHeba M EltahirAisha AlhaddadFahad Dakilallah AljohaniTarraji Mohammed AlmuzainiMekky M AbouziedAhmed Aldhafiri

Published in: Journal of clinical laboratory analysis (2023)

Having the most significant correlations, IL-6 high levels in mechanically ventilated patients were shown to affect laboratory results, and, therefore, is suggested as a severity biomarker of COVID-19.

Keyphrases

sars cov
end stage renal disease
newly diagnosed
oxidative stress
intensive care unit
coronavirus disease
ejection fraction
acute respiratory distress syndrome
prognostic factors
patient reported outcomes